Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Repaglinide-ethyl-d5 (CAS 1217709-85-7)

0.0(0)
Write a reviewAsk a question

Application:
Repaglinide-ethyl-d5 is a non-sulfonylurea oral hypoglycemic agent
CAS Number:
1217709-85-7
Molecular Weight:
457.62
Molecular Formula:
C27H31D5N2O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Repaglinide-ethyl-d5 is involved in the regulation of glucose metabolism by binding to specific receptors on the surface of pancreatic beta cells. This binding triggers a series of intracellular events that result in the exocytosis of insulin-containing vesicles, leading to an increase in insulin secretion. This increase in insulin levels helps to lower blood glucose levels by promoting the uptake and utilization of glucose by peripheral tissues. Repaglinide-ethyl-d5 inhibits the release of glucagon, a hormone that opposes the action of insulin and promotes the release of glucose from the liver.


Repaglinide-ethyl-d5 (CAS 1217709-85-7) References

  1. Multi-component plasma quantitation of anti-hyperglycemic pharmaceutical compounds using liquid chromatography-tandem mass spectrometry.  |  Wang, M. and Miksa, IR. 2007. J Chromatogr B Analyt Technol Biomed Life Sci. 856: 318-27. PMID: 17689303
  2. Estimation of the Contribution of CYP2C8 and CYP3A4 in Repaglinide Metabolism by Human Liver Microsomes Under Various Buffer Conditions.  |  Kudo, T., et al. 2017. J Pharm Sci. 106: 2847-2852. PMID: 28238899
  3. Development of a new LC-MS/MS method for the simultaneous identification and quantification of 13 antidiabetic drugs in human hair.  |  Arbouche, N., et al. 2022. J Chromatogr B Analyt Technol Biomed Life Sci. 1205: 123335. PMID: 35716545

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Repaglinide-ethyl-d5, 1 mg

sc-219962
1 mg
$350.00

Repaglinide-ethyl-d5, 1 mg

sc-219962-CW
1 mg
$516.00